Get started
Author

Issouf Fofana

Observed name: Fofana Issouf
Observed institution: Université Nangui Abrogoua
ORCID: 0009-0004-9000-9224
Observed ORCID: 0009-0004-9000-9224
OpenAlex ID: A5096633374
Improved Inhibitors Targeting the Thymidylate Kinase of Multidrug-Resistant Mycobacterium tuberculosis with Favorable Pharmacokinetics
2025 · Souleymane Konate, Koffi N’Guessan Placide Gabin Allangba, et al. · Life · 7
Molecular Modelling and Virtual Screening. Application to the Computer-aided Design of Anticancer Inhibitors With a Favorable Pharmacokinetic Profile Against E6 Papillomavirus Type 16
2024 · Ingrid Clémence Bléhoué, Mawa Koné, et al. · Universal Journal of Pharmaceutical Research · 5
PDF
Structure-Based Design of Tetrahydroisoquinoline-Based Hydroxamic Acid Derivatives Inhibiting Human Histone Deacetylase 8
2021 · Eugene Megnassan, Issouf Fofana, et al. · SDRP Journal of Computational Chemistry & Molecular Modelling · 2
PDF
In Silico Optimization of Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2
2025 · Issouf Fofana, Brice Dali, et al. · Life · 1
Identification of Novel Polyketide Synthase 13 of Mycobacterium Tuberculosis Inhibitors: A Modelling Approach Using the Pharmacophore Method -Based Virtual Screening
2025 · Djako Akassa Marius Bernard, Niaré Adama, et al. · Journal of Advances in Medical and Pharmaceutical Sciences · 1
Virtual Design of Novel of Orally Bioavailable Piperazine Inhibitors of Enoyl-acyl Carrier Protein Reductase of Mycobacterium Tuberculosis With Favorable Pharmacokinetic Profiles
2024 · Koffi Charles Kouman, Affiba Florance Kouassi, et al. · Universal Journal of Pharmaceutical Research · 1
PDF
Structure-Based Design and In silico Evaluation of Novel Donepezil Analogues as Potent Inhibitors of Human Acetylcholinesterase for Alzheimer's Disease Therapy
2025 · Issouf Fofana, Aboubakar Traoré, et al. · Journal of Pharmaceutical Research International
Works count: 7
Citation count: 17
H-index: 2
I10-index:
Year
Topic
Type